PND95 EPTINEZUMAB DEMONSTRATED EARLY AND SUSTAINED REDUCTIONS IN HIT-6 TOTAL AND ITEM SCORES OVER TIME IN PATIENTS WITH CHRONIC MIGRAINE IN THE PROMISE-2 TRIAL
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI